Home > Insider Trading > Filing (0001562180-24-005659)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1560241	G1 Therapeutics Inc.	GTHX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1274071	L Terry Murdock	700 Park Offices Drive, Suite 200 Research Triangle Park NC 27709	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-07-05	2,475	$2.51	128,012	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the Reporting Person.
The price represents the weighted average price with a low of $2.47 and a high of $2.545. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents (i) 21,150 shares of common stock; (ii) 1,375 RSUs from award granted on January 4, 2021; (iii) 4,500 RSUs from award granted on January 3, 2022; (iv) 11,187 RSUs from award granted on January 3, 2023; (v) 17,500 RSUs from award granted on May 10, 2023; and (vi) 37,300 RSUs from award granted on January 3, 2024; and (vii) 35,000 RSUs from award granted on July 1, 2024.